Award-winning Talking Medicines structures the unstructured voice of the patient on launched medicines. They inform pharmaceutical marketing departments on who is really using their medicines and how, and what they really think of their brands. Talking Medicines’ real-time insights work within the compliance framework for the sector to replace traditional focus groups, and prescriber reports, and to inform clinical profiles.